La cadena de opciones muestra datos clave de las opciones de acciones de Clearwater Paper a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Clearwater Paper..

Clearwater Paper (NYSE:CLW) Bolsa, Cadena de Opciones

CLEARWATER PAPER CORP

Clearwater Paper

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

ABNB

BLAC

BSLK

CNSP

FFIE

INFA

JRSH

MBRX

MYNA

PCLA

SLSR

STAI

STVN

VRPX

ZCAR

Airbnb supera expectativas de ingresos y sus acciones suben un 13,9% en premercado. Descubre qué otros valores están destacando hoy.

Acciones de Airbnb (ABNB) suben alrededor del 14%; 20 acciones que se mueven en el premercado de EE.UU.

AADI

APTO

CADL

CARA

HUMA

MESO

MOBX

MTEM

NVNI

OCEA

PRFX

QUBT

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

WIIM

Clearwater Paper shares are trading higher. The company reported Q1 financial results.

Clearwater Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.04) by 850 percent. This is a 136.89 percent decrease over earnings of $1.03 per share from the same period last year. The company reported quarterly sales of $378.20 million which missed the analyst consensus estimate of $387.00 million by 2.27 percent. This is a 23.78 percent decrease over sales of $496.20 million the same period last year.

Earnings

Earnings Misses

News

Clearwater Paper Q1 EPS $(0.38) Misses $(0.04) Estimate, Sales $378.20M Miss $387.00M Estimate

ACGL

AEYE

AMSF

APAM

ARCB

ARCC

ASTE

ASTL

ATRC

BBIO

BBVA

BGFV

BKNG

BRSP

CECO

CHCT

CLVT

CSGP

CVLT

DHIL

ENSG

ENVA

ESRT

ETWO

EXLS

FELE

FFIC

FIBK

FICO

FOUR

FRSH

FRST

FSLR

FYBR

HLMN

HOUS

HRZN

HSBC

HURN

ILPT

INCY

INTZ

JAKK

JBGS

JBLU

KNSA

LFUS

LGIH

Laboratory Corporation Of America Holdings

LOGI

LXFR

Earnings Scheduled For April 29, 2025

Clearwater Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Clearwater Paper to report an earnings per share (EPS) of $0.17.
Investors in Clearwater Paper are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings Track Record</h3>
Last quarter the company missed EPS by $0.84, which was followed by a 8.36% drop in the share price the next day.
Here's a look at Clearwater Paper's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.33</td>
<td>0.29</td>
<td>0.30</td>
<td>1.11</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-1.17</td>
<td>0.35</td>
<td>-0.53</td>
<td>1.43</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-8.0%</td>
<td>11.0%</td>
<td>-21.0%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745870503_0.png" alt="eps graph" />
<h3>Market Performance of Clearwater Paper's Stock</h3>
Shares of Clearwater Paper were trading at $24.42 as of April 25. Over the last 52-week period, shares are down 46.01%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<h3>Analyst Views on Clearwater Paper</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Clearwater Paper.
A total of 1 analyst ratings have been received for Clearwater Paper, with the consensus rating being Outperform. The average one-year price target stands at $37.0, suggesting a potential 51.52% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Mercer Intl, Magnera and Sylvamo, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Mercer Intl, with an average 1-year price target of $6.0, suggesting a potential 75.43% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Magnera, with an average 1-year price target of $24.0, suggesting a potential 1.72% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Sylvamo, with an average 1-year price target of $80.0, suggesting a potential 227.6% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
The peer analysis summary provides a snapshot of key metrics for Mercer Intl, Magnera and Sylvamo, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Clearwater Paper</td>
<td>Outperform</td>
<td>44.12%</td>
<td>$14.70M</td>
<td>26.21%</td>
</tr>
<tr>
<td>Mercer Intl</td>
<td>Neutral</td>
<td>3.81%</td>
<td>$76.18M</td>
<td>3.53%</td>
</tr>
<tr>
<td>Magnera</td>
<td>Outperform</td>
<td>119.11%</td>
<td>$71M</td>
<td>-9.14%</td>
</tr>
<tr>
<td>Sylvamo</td>
<td>Neutral</td>
<td>0.62%</td>
<td>$237M</td>
<td>9.08%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Clearwater Paper ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.
<h3>Get to Know Clearwater Paper Better</h3>
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
<h3>Understanding the Numbers: Clearwater Paper's Finances</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Clearwater Paper's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 44.12%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Clearwater Paper's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 51.43%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Clearwater Paper's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 26.21%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Clearwater Paper's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.55% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Clearwater Paper's debt-to-equity ratio is below the industry average at 0.34, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/CLW/earnings">To track all earnings releases for Clearwater Paper visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Clearwater Paper's Earnings

RBC Capital analyst Matthew McKellar reiterates Clearwater Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) with a Outperform and maintains $37 price target.

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Outperform on Clearwater Paper, Maintains $37 Price Target

Clearwater Paper shares are trading lower following a Q4 adjusted EPS miss.

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Friday.
Shares of Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) fell sharply in today's pre-market trading after the company issued second-quarter revenue guidance <a href="https://in.benzinga.com/25/02/43715360/applied-materials-stock-slides-after-q1-report-weak-q2-revenue-guidance">below estimates</a>.
Applied Materials reported quarterly earnings of $2.38 per share which beat the $2.29 analyst consensus estimate. Quarterly revenue came in at $7.17 billion, beating the $7.14 billion consensus estimate. The company sees second-quarter earnings of $2.30 per share, plus or minus 18 cents, versus the $2.30 estimate and revenue of $7.1 billion, plus or minus $400 million, versus the $7.21 billion estimate.
Applied Materials shares tumbled 5.1% to $174.81 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Informatica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFA#NYSE">INFA</a>) shares dipped 35.6% to $16.21 in pre-market trading after the company reported worse-than-expected fourth-quarter sales results and issued FY25 revenue guidance below estimates.</li>
<li>Solaris Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#NYSE">SLSR</a>) declined 22.5% to $3.20 in pre-market trading after gaining 3% on Thursday.</li>
<li>Stevanato Group S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STVN#NYSE">STVN</a>) fell 16.1% to $16.01 in pre-market trading after declining 5% on Thursday.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) shares fell 13.2% to $25.25 in pre-market trading following downbeat quarterly earnings.</li>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) dipped 12.3% to $13.37 in pre-market trading. Nvidia reported it dissolved share stake in Soundhound in 13F.</li>
<li>Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) fell 8.6% to $134.49 in pre-market trading following weak first-quarter guidance.</li>
<li>DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) fell 7.9% to $163.00 in pre-market trading after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook for 2025 as it announced its results after the market closed on Thursday.</li>
<li>Moderna, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) fell 6.3% to $29.89 in pre-market trading following fourth-quarter results.</li>
<li>Stevanato Group S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STVN#NYSE">STVN</a>) fell 5.6% to $18.00 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43692962/top-3-consumer-stocks-you-may-want-to-dump-in-february">Top 3 Consumer Stocks You May Want To Dump In February</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

AMAT

MRNA

SOUN

TWLO

Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Shares of Airbnb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) rose sharply in today's pre-market trading after the company reported its <a href="https://in.benzinga.com/general/market-summary/25/02/43722350/airbnb-crushes-q4-estimates-as-classic-hotel-users-flock-to-short-term-rentals-heres-whats-driving-the-surge-in-nights-and-experiences">fourth-quarter financial results.</a>
Airbnb reported quarterly revenue of $2.5 billion which beat the $2.42 billion analyst consensus estimate and represents an increase of 12% year-over-year.&nbsp; The company said the increase in revenue was driven by strong growth in nights stayed and a modest increase in ADR.
Airbnb shares jumped 13.9% to $160.58 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) gained 78.4% to $0.5157 in pre-market trading after the company announced it confirmed positive results from its Probudur for combat care study with the U.S. Army.</li>
<li>Moleculin Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) rose 62.2% to $2.06 in pre-market trading after jumping 202% on Thursday. The company received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 pivotal trial protocol evaluating Annamycin in combination with Cytarabine (also known as Ara-C and for which the combination of Annamycin and Ara-C is referred to as AnnAraC) for refractory/relapsed Acute Myeloid Leukemia patients.</li>
<li>Zoomcar Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares jumped 36.4% to $2.02 in pre-market trading ahead of quarterly earnings.</li>
<li>ScanTech AI Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAI#NASDAQ">STAI</a>) gained 39.3% to $2.34 in pre-market trading after gaining 17% on Thursday.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) gained 27.2% to $2.25 in pre-market following a 21% gain in the previous session.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) shares climbed 22.4% to $0.1320 in pre-market trading after gaining around 4% on Thursday.</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) gained 20.4% to $7.73 in pre-market trading after posting upbeat quarterly earnings.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) gained 17.9% to $20.46 in pre-market trading after falling around 4% on Thursday.</li>
<li>Zhihu Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) gained 15.2% to $5.30 in pre-market trading after jumping over 10% on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>PicoCELA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCLA#NASDAQ">PCLA</a>) shares fell 54.6% to $3.65 in pre-market trading after declining around 5% on Thursday.</li>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares fell 39% to $0.2585 in pre-market trading. Mynaric shares dipped around 32% on Thursday after company announced it received a delisting notification from the Nasdaq.</li>
<li>Unifi, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UFI#NYSE">UFI</a>) dipped 34.5% to $3.70 in pre-market trading after gaining 11% on Thursday.</li>
<li>Bellevue Life Sciences Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLAC#NASDAQ">BLAC</a>) fell 36.3% to $4.29 in today's pre-market trading. The company announced approval for a business combination proposal and name change with OSR Holdings beginning on February 18.</li>
<li>Jerash Holdings (US), Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRSH#NASDAQ">JRSH</a>) fell 37% to $2.40 in pre-market trading.</li>
<li>Informatica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFA#NYSE">INFA</a>) shares tumbled 35.6% to $16.21 in pre-market trading after the company reported worse-than-expected fourth-quarter sales results and issued FY25 revenue guidance below estimates.</li>
<li>Bolt Projects Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>) declined 31.8% to $0.8393 in pre-market trading. Bolt Projets Holdings shares jumped 303% on Thursday after the company, on X, posted, &#8220;Another exciting partnership coming soon, powered by Bolt.&#8221;</li>
<li>Solaris Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#NYSE">SLSR</a>) fell 22.5% to $3.20 in pre-market trading after gaining 3% on Thursday.</li>
<li>Stevanato Group S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STVN#NYSE">STVN</a>) fell 16.1% to $16.01 in pre-market trading after declining 5% on Thursday.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) shares dipped 13.2% to $25.25 in pre-market trading following downbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43692962/top-3-consumer-stocks-you-may-want-to-dump-in-february">Top 3 Consumer Stocks You May Want To Dump In February</a></li>
</ul>

Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Clearwater Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) reported quarterly losses of $(1.17) per share which missed the analyst consensus estimate of $(0.33) by 254.55 percent. This is a 186.67 percent decrease over earnings of $1.35 per share from the same period last year. The company reported quarterly sales of $483.000 million which beat the analyst consensus estimate of $473.000 million by 2.11 percent. This is a 5.81 percent decrease over sales of $512.800 million the same period last year.

Earnings Beats

Clearwater Paper Q4 2024 Adj. EPS $(1.17) Misses $(0.33) Estimate, Sales $483.000M Beat $473.000M Estimate

AENT

AGIO

ALNY

APDN

ATUS

AVNT

BENF

BFAM

BLIN

BPMC

BRKR

BTOC

CBRE

CEVA

CLBT

CNVS

COHU

COIN

CROX

CYBR

DDOG

DKNG

DNOW

DXCM

EEFT

EGAN

ELME

ELVA

FBRT

FROG

GDDY

GEHC

GPMT

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HIMX

HTGC

IMPP

IRDM

IRMD

ISSC

KELYA

KELYB

KNSL

LECO

LGCY

LPTH

NTWK

NVMI

Earnings Scheduled For February 13, 2025

Disclosed on January 6, JOE LAYMON, Board Member at Clearwater Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: After conducting a thorough analysis, LAYMON sold 4,354 shares of Clearwater Paper. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001441236/000200854525000007//Archives/edgar/data/1441236/000200854525000007/0002008545-25-000007-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total transaction value is $128,507.
Clearwater Paper's shares are actively trading at $29.3, experiencing a down of 0.0% during Tuesday's morning session.
<h3>Delving into Clearwater Paper's Background</h3>
Clearwater Paper Corp is engaged in the manufacturing and selling of private label tissue, paperboard, and pulp-based products. The company has two reportable segments namely the consumer products segment which manufactures and sells a complete line of at-home tissue products as well as AFH products. The pulp and paperboard segment manufactures and markets bleached paperboard for the high-end segment of the packaging industry as well as offers services that include custom sheeting, slitting and cutting of paperboard. It generates maximum revenue from Pulp and Paperboard segment. Geographically, it derives maximum revenue from the United States.
<h3>Financial Insights: Clearwater Paper</h3>
Positive Revenue Trend: Examining Clearwater Paper's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 41.02% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 7.65%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Clearwater Paper's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.35.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.75, caution is advised due to increased financial risk.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 1465.0 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.22 is lower than the industry average, implying a discounted valuation for Clearwater Paper's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 10.46 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Unlocking the Meaning of Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001441236">Check Out The Full List Of Clearwater Paper's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Transaction: JOE LAYMON Sells $128K Worth Of Clearwater Paper Shares

<a href="https://valorinternational.globo.com/business/news/2024/12/23/suzano-mulls-acquisition-to-expand-presence-in-us-packaging-market.ghtml" title="https://valorinternational.globo.com/business/news/2024/12/23/suzano-mulls-acquisition-to-expand-presence-in-us-packaging-market.ghtml">https://valorinternational.globo.com/business/news/2024/12/23/suzano-mulls-acquisition-to-expand-presence-in-us-packaging-market.ghtml</a>

"Suzano Mulls Acquisition To Expand Presence In U.S. Packaging Market; Brazilian Pulp Maker Eyes Clearwater Paper In Line With Strategy To Scale Up In Rapidly Growing Markets" - Valor International

U.S. stocks were higher, with the Dow Jones index gaining over 300 points on Friday.
Shares of Mission Produce, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVO#NASDAQ">AVO</a>) rose sharply during today's session after the company reported <a href="https://www.benzinga.com/news/earnings/24/12/42605747/mission-produce-shares-grow-after-strong-q4-results-details">better-than-expected fourth-quarter sales results.</a>
Mission Produce reported quarterly earnings of 28 cents per share and quarterly revenue of $354.4 million, which beat the analyst consensus estimate of $220.4 million.
Mission Produce shares jumped 22.3% to $15.07 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Humacyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) shares jumped 55.2% to $5.37 after the company announced FDA approval for SYMVESS for treating extremity vascular injuries. HC Wainwright &amp; Co. raised its price target on the stock from $12 to $15.</li>
<li>Personalis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>) gained 32% to $6.94 after the company and Moderna recently announced a multi-year extension to continue utilizing the Personalis ImmunoID NeXT platform and technology for V940/mRNA-4157. The company also announced an investment from Merck.</li>
<li>Enovix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>) gained 22% to $9.80 as the company shipped first EX-2M samples to mobile phone customers.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) surged 21.2% to $29.96.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) gained 20.2% to $8.99.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) gained 20% to $18.17. In an exchange filing dated December 20, Quantum Computing has registered up to 8.96 million shares for resale by selling stockholders.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) surged 20% to $3.58 as the company posted upbeat quarterly earnings.</li>
<li>IonQ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) gained 15.5% to $ 43.63. Craig-Hallum analyst Richard Shannon maintained IonQ with a Buy and raised the price target from $22 to $45.</li>
<li>Sirius XM Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) rose 10% to $22.59. Warren Buffett acquired 4.96 million Sirius XM shares at an average price of $21.60.</li>
<li>Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) gained 9.7% to $2.5248.</li>
<li>Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) rose 9% to $2.8650.</li>
<li>Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) gained 6.6% to $13.93.</li>
<li>Occidental Petroleum Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) gained 4.7% to $47.47 after Berkshire Hathaway increased its stake in the company.</li>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) rose 2.1% to $133.38. The European Commission on Thursday announced it approved the proposed acquisition of Run:ai Labs by NVIDIA.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42616304/top-3-risk-off-stocks-that-may-collapse-this-month">Top 3 Risk Off Stocks That May Collapse This Month</a></li>
</ul>

Intraday Update

ENVX

IONQ

LCID

NVDA

PLUG

PSNL

RGTI

RIVN

SIRI

Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday

Shares of FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) rose sharply in today's pre-market trading as the company posted stronger-than-expected <a href="https://www.benzinga.com/news/earnings/24/12/42605034/fedex-stock-rallies-on-better-than-expected-q2-eps-freight-spin-off-announcement">results for its second quarter</a>.
The company also announced that it has decided to pursue a full separation of FedEx Freight through the capital markets, creating a new publicly traded company.
FedEx shares jumped 8.7% to $299.80 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Aptose Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) gained 80.5% to $0.3070 in pre-market trading after the company announced it was granted an extension to provide compliance evidence for a continued Nasdaq listing.</li>
<li>Psyence Biomedical Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) gained 67.4% to $4.12 in pre-market trading fater jumping more than 60% on Thursday. The company announced it has entered into an IP licensing and mutual exclusivity agreement with Optimi Health Corp.</li>
<li>Ocean Biomedical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) climbed 62.5% to $0.9576 in pre-market trading.</li>
<li>Nvni Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) gained 52.8% to $4.08 in pre-market trading after jumping 317% on Thursday.</li>
<li>Humacyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) rose 44.5% to $5.00 in pre-market trading as the company announced the FDA approval of SYMVESS&#x2122; (acellular tissue engineered vessel-tyod) for the treatment of extremity vascular trauma.</li>
<li>Aadi Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AADI#NASDAQ">AADI</a>) gained 35.3% to $3.14 in pre-market trading after the company secured $100 million PIPE financing and announced the sale of FYARRO for $100 million.</li>
<li>Xilio Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLO#NASDAQ">XLO</a>) gained 26.9% to $1.19 in pre-market trading after the company announced 7.85 million of its shares was acquired by Gilead Sciences.</li>
<li>ZJK Industrial Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) rose 17.4% to $8.78 in pre-market trading after dipping over 12% on Thursday.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) gained 11.8% to $27.62 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Molecular Templates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) shares tumbled 49.5% to $0.1785 in pre-market trading after the company announced notice of delisting and failure to satisfy continued listing rules.</li>
<li>PainReform Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFX#NASDAQ">PRFX</a>) declined 36.4% to $7.10 in pre-market trading after jumping around 410% on Thursday.</li>
<li>Cara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares fell 26.7% to $0.2998 in pre-market trading after jumping 56% on Thursday. Cara Therapeutics recently announced it entered into an all-stock merger with Tvardi Therapeutics.</li>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) fell 25.8% to $76.80 in pre-market trading. Novo Nordisk said CagriSema demonstrated weight loss in adults with obesity or overweight in the REDEFINE 1 trial.</li>
<li>XChange TEC.INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHG#NASDAQ">XHG</a>) shares dipped 25.2% to $0.9730 in pre-market trading after climbing 65% on Thursday.</li>
<li>Mobix Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) fell 24.5% to $1.57 in today's pre-market trading after reporting third-quarter results.</li>
<li>Zoomcar Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) dipped 23.6% to $1.94 in pre-market trading. Zoomcar said it launched Zoomcar Cabs, which are affordable car rentals with drivers as a new offering.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares fell 18.1% to $13.72 in pre-market trading. Mesoblast shares jumped over 36% on Thursday after the company announced the FDA approved Ryoncilas the first mesenchymal stromal cell therapy in the United States.</li>
<li>Candel Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CADL#NASDAQ">CADL</a>) fell 13.1% to $8.66 in pre-market trading after jumping over 52% on Thursday.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) fell 11.1% to $13.46 in pre-market trading after declining 41% on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42609619/sp-500-nasdaq-end-in-red-as-investor-sentiment-declines-micron-tumbles-after-sales-miss-greed-index-in-extreme-fear-zone">S&amp;P 500, Nasdaq End In Red As Investor Sentiment Declines, Micron Tumbles After Sales Miss: Greed Index In &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>

Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Clearwater Paper shares are trading higher. RBC Capital reiterated an Outperform rating on the stock.

Clearwater Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.29 by 20.69 percent.

Clearwater Paper Q3 2024 Adj EPS $0.35 Beats $0.29 Estimate

Buybacks

Clearwater Paper Board Authorizes New $100M Share Buyback Program

S&amp;P SmallCap 600 constituent MDU Resources Group is spinning off Everus Construction Group in a transaction expected to be completed on November 1.&nbsp;
Following the spin-off, the parent company MDU Resources Group will remain in the S&amp;P SmallCap 600 but will change its Global Industry Classification Standard (GICS) sector from Industrials to Utilities.
&nbsp;Clearwater Paper is no longer representative of the small-cap market space.&nbsp;

ECGW

Everus Construction To Be Added To The S&P SmallCap 600 Effective November 1, Replacing Clearwater Paper

Press Releases

Clearwater Paper Announces Participation in Baird Global Industrial Conference

Clearwater Paper Announces the Closing of the Sale of its Tissue Business

Clearwater Paper Reports Third Quarter 2024 Results; Board Approves New $100M Share Repurchase Authorization

Clearwater Paper Announces Availability and Timing of Fourth Quarter 2024 Earnings Conference Call and Webcast

Clearwater Paper Reports Fourth Quarter and Year End 2024 Results

Comments

Clearwater Paper

Clearwater Paper (CLW) Opciones

Clearwater Paper (NYSE:CLW) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL